C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester acute myocardial infarction peptide II (LAMP II) study

Clinical Science

Volumn 121, Issue 2, 2011, Pages 79-89

  Narayan, Hafid ^a,b   Dhillon, Onkar S ^a,b   Quinn, Pauline A ^a,b   Struck, Joachim ^c   Squire, Iain B ^a,b   Davies, Joan E ^a,b   NG, Leong L ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Biomarker; Copeptin; Global registry of acute coronary events (GRACE); N terminal pro B type natriuretic peptide (NT proBNP); Relative utility

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; COPEPTIN; CREATININE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NATRIURETIC PEPTIDE TYPE C; TROPONIN I; UNCLASSIFIED DRUG; VASOPRESSIN;

ACCURACY; ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FEMALE; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS SCORE; HAZARD RATIO; HEART RIGHT VENTRICLE EJECTION FRACTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; POST HOC ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; GLYCOPEPTIDES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS;

EID: 79955634160     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100564     Document Type: Article

References (19)

1. Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey II, WE., Fesmire, F. M., Hochman, J. S., Levin, T. N. et al. (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116, 148-304.
2. Antman, E. M., Cohen, M., Bernink, P. J., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D. and Braunwald, E. (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA, J. Am. Med. Assoc. 284, 835-842.
3. Fox, K. A., Dabbous, O. H., Goldberg, R. J., Pieper, K. S., Eagle, K. A., Van de Werf, F., Avezum, A., Goodman, S. G., Flather, M. D., Anderson, Jr, F. A. and Granger, C. B. (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333, 1091.
4. Roberts, R. and Fromm, R. E. (1998) Management of acute coronary syndromes based on risk stratification by biochemical markers: an idea whose time has come. Circulation 98, 1831-1833.
5. Holwerda, D. A. (1972) A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization. Eur. J. Biochem. 28, 334-339.
6. Morgenthaler, N. G., Struck, J., Jochberger, S. and Dunser, M.W. (2008) Copeptin: clinical use of a new biomarker. Trends Endocrinol. Metab. 19, 43-49.
7. Khan, S. Q., Dhillon, O. S., O'Brien, R. J., Struck, J., Quinn, P. A., Morgenthaler, N. G., Squire, I. B., Davies, J. E., Bergmann, A. and Ng, L. L. (2007) C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 115, 2103-2110.
8. Thygesen, K., Alpert, J. S. and White, H. D. (2007) Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur. Heart J. 28, 2525-2538.
9. Smilde, T. D., van Veldhuisen, D. J., Navis, G., Voors, A. A. and Hillege, H. L. (2006) Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114, 1572-1580.
10. Omland, T., Persson, A., Ng, L. L., O'Brien, R., Karlsson, T., Herlitz, J., Hartford, M. and Caidahl, K. (2002) N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 106, 2913-2918.
11. R Development Core Team (2010) R: a language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria (http://www.R-project.org/).
12. Hanley, J. A. and McNeil, B. J. (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36.
13. Pencina, M. J., D'Agostino, Sr, R. B., D'Agostino, Jr, R. B. and Vasan, R. S. (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157-172.
14. Baker, S. G., Cook, N. R., Vickers, A. and Kramer, B. S. (2009) Using relative utility curves to evaluate risk prediction. J. R. Stat. Soc. Ser. A Stat. Soc. 172, 729-748.
15. Bhandari, S. S., Loke, I., Davies, J. E., Squire, I. B., Struck, J. and Ng, L. L. (2009) Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin. Sci. 116, 257-263.
16. Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P. and Braunwald, E. (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105, 1760-1763.
17. Cook, N. R. (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115, 928-935.
18. Morrow, D. A. and de Lemos, J. A. (2007) Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115, 949-952.
19. Baker, S. G. (2009) Putting risk prediction in perspective: relative utility curves. J. Natl. Cancer Inst. 101, 1538-1542.